Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |